Spondyloarthritis (SpA), if not diagnosed and treated early, often leads to significant morbidity. Unfortunately, diagnosis and implementation of therapy are frequently delayed, in many cases by ...

New features of the Assessment of SpondyloArthritis International Society axial spondyloarthritis criteria The concept of nonradiographic axial spondyloarthritis. Recognition of a role of MRI in ...

Many physicians who treat patients with chronic back pain lack the knowledge to identify people with axial spondyloarthritis, ...

The global axial spondyloarthritis market is set for significant growth, with forecasts indicating a robust CAGR of 14.8% during the period from 2022 to 2028. This growth is primarily attributed to ...

Inflammatory arthritis is a collective term for a group of conditions, including rheumatoid arthritis (RA) and spondyloarthritis (SpA), that cause inflammation of the tissues around affected joints.

Upadacitinib sustains its efficacy in non-radiographic axial spondyloarthritis through 2 years without presenting any new ...

The chronic back pain of axial spondyloarthritis (axSpA) may be accompanied after diagnosis by three primary extra-musculoskeletal manifestations -- uveitis, psoriasis, or inflammatory bowel ...

Tyler J. Ashton is biking across Canada through biting winter winds and freezing rain, turning his daily battle with chronic ...

A new Boston biotech has emerged from stealth with $67 million in venture capital and plans to bring its first autoimmune ...